Tianda Pharmaceutical
Manufacturing · China · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Citic Tower 24 Tim Mei Ave L No 1, Centr...Phone Number
+852 25453313Website
www.tiandapharma.comRevenue
$66.9 MillionStock Symbol
455Industry
About Tianda Pharmaceutical
Tianda Pharmaceutical Org Chart
Is Tianda Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Tianda Pharmaceutical recently announced quarterly report
Check if Tianda Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Tianda Pharmaceutical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Tianda Pharmaceutical
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Tianda Pharmaceutical launches new products
Click to see if Tianda Pharmaceutical had a recent Job posting/layoffs
Tianda Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Tianda Pharmaceutical has new funding data
Recommended Actions
Find VP level buyers at Tianda Pharmaceutical
Find 3 more new buyers
Company Profile Activity
Activity Insights
Tianda Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tianda Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tianda Pharmaceutical.
Tianda Pharmaceutical Tech Stack
A closer look at the technologies used by Tianda Pharmaceutical
Tianda Pharmaceutical News & Media
Tianda Pharmaceuticals Annual Results 2022
HONG KONG, Jun 30, 2022 - (ACN Newswire) - Tianda Pharmaceuticals Limited (Tianda Pharmaceuticals or the Group, stock code: 0455.HK) is pleased to announce its annual results for the year ended 31 March 2022. During the Reporting Period, the Group's business attained further development as revenue reached HK$510.0 million for the Current Financial Year, representing an increase of 7.5% compared to last year. Innovation and R&D made steady progress with R&D expenses increasing 34.7% yearTianda Pharma Interim Results 2021
HONG KONG, Nov 26, 2021 - (ACN Newswire) - Tianda Pharmaceuticals Limited (Tianda Pharma or the Group, stock code: 0455.HK) is pleased to announce its interim results for the six months ended 30 September 2021 (the "Reporting Period"). During the Reporting Period, all three business segments of the Group recorded significant business growth, with the total revenue reaching HK$236.5 million, representing an increase of 26.2% year on year (YOY). The Group's financial position remains strong,Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout
HONG KONG, Mar 4, 2021 - (ACN Newswire) - Tianda Pharmaceuticals Limited ("Tianda Pharmaceuticals", together with its subsidiaries as the "Group", Stock Code: 455.HK) is pleased to announce that its wholly-owned subsidiary, Tianda Pharmaceutical (Zhuhai) Co., Ltd., has entered into a Technology Transfer Contract with Heilongjiang Jiren Pharmaceutical Co., Ltd. to acquire the latter's whole technology ownership and all the intellectual rights in Xiaoer Qingre Zhike Granule, National medicine regiTianda Pharmaceuticals acquired and established a long-term relationship of Cooperation with Yeung & Young Medicare and Qi's Living
HONG KONG, Oct 6, 2020 - (ACN Newswire) - Tianda Pharmaceuticals Limited ("Tianda Pharmaceuticals", together with its subsidiaries as the "Group", Stock Code: 455.HK) is pleased to announce that its wholly-owned subsidiary, TDMall (Hong Kong) Limited ("TDMall HK"), has completed the acquisition of 50.1% equity interests in each of Yeung & Young Medicare Centre Limited ("Yeung & Young") and Qi's Living Company Limited ("Qi's Living") at a total consideration of HK$25 million. Yeung & Young
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tianda Pharmaceutical
Tianda Pharmaceutical Co., Ltd. focuses on the development of traditional Chinese medicine and innovative pharmaceuticals, aiming to provide high-quality medical and healthcare services. The company is committed to becoming a competitive player in the pharmaceutical industry by establishing a comprehensive supply chain for traditional Chinese medic... Read More